← FDA Warning Letters
Pharmacy2Home/LandiCom Holding LTD
FDA Warning Letter · 2022-02-15 · Center for Drug Evaluation and Research | CDER
Letter
- Company
- Pharmacy2Home/LandiCom Holding LTD
- Posted Date
- 2022-02-15
- Letter Issue Date
- 2022-02-03
- Issuing Office
- Center for Drug Evaluation and Research | CDER
Subject
Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown